Table 1 Correlation between UCA1 expression and clinicopathological characteristics of renal cell cancer patients [3, 48, 49] (Clear cell renal cell carcinoma)
Characteristics | Total | Expression of UCA1 | P value | |
|---|---|---|---|---|
High (n = 60) | Low (n = 28) | |||
Gender | ||||
 Male | 47 | 35 (74.5%) | 12 (25.5%) | 0.251 |
 Female | 41 | 25 (61.0%) | 16 (39.0%) |  |
Tumor size (cm) | ||||
  ≤ 7 cm | 50 | 33 (66.0%) | 17 (34.0%) | 0.651 |
 >7 cm | 38 | 27 (71.0%) | 11 (28.9%) |  |
Age | ||||
 ≤ 55 | 42 | 28 (66.7%) | 14 (33.3%) | 0.821 |
  > 55 | 46 | 32 (69.6%) | 14 (30.4%) |  |
Differentiation | ||||
 Moderate/poor | 50 | 40 (68.2%) | 10 (31.8%) | 0.010* |
 Well | 38 | 20 (52.6%) | 18((47.4%) |  |
TNM stage | ||||
 T0–1 | 26 | 14 (53.8%) | 12 (46.2%) | 0.080 |
 T2–4 | 62 | 46 (74.2%) | 16 (25.8%) |  |
Lymph node metastasis(N) | ||||
 N0 | 79 | 56 (70.9%) | 23 (29.1%) | 0.136 |
 N1 or above | 9 | 4 (44.4%) | 5 (55.6%) |  |